Accredo Health Group

Accredo Health Group
Name	Accredo Health Group
Type	Subsidiary
Industry	Pharmaceuticals
Founded	1996
Headquarters	Bloomington, Minnesota
Area served	United States
Parent	Express Scripts

Accredo Health Group is a specialty pharmaceutical provider offering high-cost, high-touch medication services and care coordination for patients with complex, chronic conditions. The organization operates within the specialty pharmacy sector alongside firms such as CVS Health, Walgreens Boots Alliance, Humana, UnitedHealth Group, and Cigna. Accredo's operations intersect with stakeholders including pharmaceutical manufacturers like Pfizer, Johnson & Johnson, Amgen, Novartis, and Roche as well as payers such as Medicare (United States), Medicaid, and commercial insurers.

History

Accredo began in 1996 amid consolidation trends that also involved companies such as Cardinal Health, McKesson Corporation, Walgreens, Rite Aid, and Express Scripts. The company expanded through acquisitions and integration with specialty distributors and pharmacy benefit managers like Catalyst Health Solutions and Medco Health Solutions. In 2009–2012 industry realignments featuring Express Scripts and competitors CVS Caremark reshaped the specialty pharmacy landscape, influencing Accredo’s strategic positioning. Subsequent corporate transactions in the 2010s involved mergers and antitrust scrutiny similar to cases with Mylan N.V. and Allergan, while regulatory developments from entities such as the United States Department of Justice and the Federal Trade Commission affected market behavior.

Services and Specialties

Accredo provides specialty pharmacy services concentrating on therapeutic areas treated by biologics and oral specialty drugs, comparable to services offered by BioMarin Pharmaceutical, Gilead Sciences, Bristol-Myers Squibb, Eli Lilly and Company, and Takeda Pharmaceutical Company. Core offerings include specialty medication dispensing, medication adherence programs, infusion support parallel to services of Option Care Health and Kaiser Permanente, and complex reimbursement management like those handled by Accenture consultants for healthcare clients. Accredo manages therapies for conditions such as multiple sclerosis, oncology, HIV, hepatitis C, rheumatoid arthritis, and rare diseases treated by orphan drugs from firms like Vertex Pharmaceuticals and Regeneron Pharmaceuticals.

Clinical Programs and Patient Support

Accredo delivers clinical management programs that mirror disease management approaches used by Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, and academic medical centers including Massachusetts General Hospital and UCLA Health. Services include nurse-led counseling, specialty infusion coordination, prior authorization assistance with payers like Anthem, Inc., and patient education linked to clinical guidelines from organizations such as the American Medical Association, American Society of Clinical Oncology, American Academy of Neurology, and Infectious Diseases Society of America. Case management often involves coordination with manufacturers’ patient assistance programs from groups like Patient Assistance Foundation and nonprofit partners including American Cancer Society and National Organization for Rare Disorders.

Corporate Structure and Ownership

Accredo operates as a subsidiary under the umbrella of a larger pharmacy benefit manager, reflecting ownership patterns seen in firms like Express Scripts and historical consolidations involving Medco Health Solutions and Cigna Corporation. Board-level governance and executive leadership draw on practices common to public companies such as Thermo Fisher Scientific and GE Healthcare, while corporate compliance aligns with standards from bodies like the Securities and Exchange Commission and accreditation from URAC. Strategic partnerships and vendor agreements often involve logistics and distribution players such as UPS and FedEx.

Financial Performance and Markets

As part of a larger PBM and healthcare conglomerate, Accredo’s revenue contributions are contextualized within consolidated financial statements similar to Express Scripts Holding Company and peer reporting by CVS Health Corporation. Market dynamics affecting specialty pharmacy revenues include drug pricing trends driven by manufacturers like Amgen and Novartis, payer reimbursement policies from Centers for Medicare & Medicaid Services, and wholesale acquisition costs monitored by Agency for Healthcare Research and Quality. Investment analysts covering the sector include firms such as Goldman Sachs, J.P. Morgan Chase, Morgan Stanley, and Bank of America Merrill Lynch.

Regulatory and Legal Issues

Accredo’s operations are subject to regulatory oversight from agencies including the Food and Drug Administration, Centers for Medicare & Medicaid Services, Drug Enforcement Administration, and state boards of pharmacy such as those in Minnesota. Legal matters in the specialty pharmacy industry have involved litigation and settlements comparable to cases with McKesson Corporation and Teva Pharmaceuticals, encompassing alleged reimbursement disputes, copay assistance considerations, and compliance with Health Insurance Portability and Accountability Act of 1996 provisions. Antitrust and competition issues reflect broader sector inquiries by the Federal Trade Commission and United States Department of Justice.

Community Engagement and Partnerships

Accredo participates in community outreach and partnerships with patient advocacy organizations and nonprofit groups such as American Heart Association, American Diabetes Association, Susan G. Komen, and rare disease advocacy organizations like Global Genes and Rare Disease Legislative Advocates. Corporate social responsibility efforts align with initiatives common to healthcare companies including workforce development collaborations with institutions like University of Minnesota, philanthropic grants to community health centers similar to Community Health Center, Inc., and employee volunteer programs comparable to those at Target Corporation.

Category:Pharmacies of the United States Category:Pharmaceutical companies established in 1996